A retrospective cohort study explored outcomes for pregnant women with HL who received antenatal chemotherapy compared with a match cohort of nonpregnant women.
No difference in event-free survival (EFS) was observed in children and adolescents with newly diagnosed Hodgkin lymphoma (HL) according to race/ethnicity; however, postrelapse mortality was found to be higher in nonwhite groups. The findings from this pooled, secondary analysis of data from phase 3 clinical trials of dose-dense, response-adapted therapy were published in the Journal…
In an assessment of data from the International Network on Cancer registry, researchers determined that maternal 5-year survival for pregnant women with HL was comparable to that of their nonpregnant counterparts.
The purpose of this study is to assess the safety, tolerability, and antitumor activity, as well as recommended dose of brentuximab vedotin in combination with a multiagent chemotherapy regimen.
A retrospective study sought to determine the risk factors for thromboembolism in patients with acute leukemia or lymphoma.
Strong positive association noted, with incidence increasing in BMIs greater than 24.2 kg/m².
Survival benefit seen for radiotherapy after ABVD regimen, but difference not statistically significant.
Prevalence higher for advanced adenomas, advanced serrated lesions, serrated polyposis syndrome.
Researchers present results of an interim analysis of a study on the prevalence of advanced colorectal neoplasia among survivors of Hodgkin lymphoma.
A retrospective evaluation of patients treated at a tertiary cancer center demonstrated that patients with Hodgkin lymphoma experienced periods of actionable distress in survivorship, despite a low overall distress burden.
